ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 021,00
0,80%
Dow Jones
38 675,68
0,00%
DAX
18 171,39
0,99%
Brent Oil
83,535
0,49%
Bitcoin
64 090,20
0,14%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Biomea Fusion Inc (BMEA)

  7. Biomea Fusion Inc (BMEA) Actualités

BMEA Biomea Fusion Inc

12,35
0,00 (0,00%)
Avant marché
Dernière mise à jour : 13:00:17
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Biomea Fusion Inc BMEA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 12,35 13:00:17
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
12,35
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202422:05GLOBEBiomea Fusion Reports First Quarter 2024 Financial Results..
01/5/202422:10GLOBEBiomea Fusion, Inc. Reports Inducement Grants under Nasdaq..
01/4/202422:10GLOBEBiomea Fusion, Inc. Reports Inducement Grants under Nasdaq..
01/4/202415:02GLOBEBiomea Fusion Highlights Initial Data from the First Two..
01/4/202415:00GLOBEBiomea Fusion Reports Fourth Quarter and Full Year 2023..
07/3/202422:02EDGAR2Form 8-K - Current report
06/3/202409:04GLOBEBiomea Fusion Presents Patient Cohorts in COVALENT-111..
01/3/202422:16GLOBEBiomea Fusion, Inc. Reports Inducement Grants under Nasdaq..
12/2/202423:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:06EDGAR2Form 8-K - Current report
09/1/202417:02GLOBEBiomea Fusion Highlights Recent Updates and Anticipated 2024..
08/1/202415:00GLOBEBiomea Fusion Announces Dosing of First Type 1 Diabetes..
05/1/202422:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/1/202422:05GLOBEBiomea Fusion to Present at the 42nd Annual J.P. Morgan..
11/12/202315:25GLOBEBiomea Fusion Presents Achievement of Minimal Residual..
09/12/202323:30GLOBEBiomea Fusion Announces Near Doubling the Percentage of..
08/12/202315:00GLOBEBiomea Fusion Presents Long-Term Follow-Up Data Showing..
07/12/202315:15GLOBEBiomea Fusion to Present Long-Term Follow-Up Data from..
05/12/202314:30GLOBEBiomea Fusion Announces Health Canada Clearance of Clinical..
27/11/202314:30GLOBEBiomea Fusion Announces Acceptance of Three Abstracts for..
16/11/202314:30GLOBEBiomea Fusion Abstract “BMF-219: A Novel Therapeutic Agent..
08/11/202322:05GLOBEBiomea Fusion to Present New Data from Ongoing Phase II..
02/11/202314:05GLOBEBiomea Fusion Announces Two Poster Presentations at Upcoming..
30/10/202321:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202321:05EDGAR2Form 8-K - Current report
30/10/202321:01GLOBEBiomea Fusion Reports Third Quarter 2023 Financial Results..
17/10/202314:30GLOBEBiomea Fusion Announces First Patient Dosed with Covalent..
05/10/202314:30GLOBEBiomea Fusion Announces FDA Clearance of Investigational New..
28/9/202314:30GLOBEBiomea Fusion Announces FDA and Health Canada Clearance of..
01/9/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202323:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/8/202314:30GLOBEBiomea Fusion Announces Appointment of Juan Pablo Frías,..
31/7/202322:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202322:08EDGAR2Form 8-K - Current report
31/7/202322:01GLOBEBiomea Fusion Reports Second Quarter 2023 Financial Results..
25/7/202322:05EDGAR2Form 8-K - Current report
24/7/202315:00GLOBEBMF-219 Induces Complete Responses in Target Acute Myeloid..
14/7/202311:45PRNUSBMEA FRAUD ALERT: Jakubowitz Law is Investigating Biomea..
12/7/202311:45PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
07/7/202311:45PRNUSBMEA FRAUD ALERT: Jakubowitz Law is Investigating Biomea..
06/7/202311:45PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
24/6/202303:54GLOBEBiomea Fusion Presents Positive Clinical Data from the..
20/6/202322:30GLOBEBiomea Fusion to Present Late Breaking Data from Ongoing..

Dernières Valeurs Consultées

NASDAQ
BMEA
Biomea Fusion
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés